Skip to main content
Article thumbnail
Location of Repository

Cigarette smoking: an important renal risk factor – far beyond carcinogenesis

By SR Orth

Abstract

In recent years, it has become apparent that smoking has a negative impact on renal function, being one of the most important remediable renal risk factors. It has been clearly shown that the risk for high-normal urinary albumin excretion and microalbuminuria is increased in smoking compared to non-smoking subjects of the general population. Data from the Multiple Risk Factor Intervention Trial (MRFIT) indicate that at least in males, smoking increases the risk to reach end-stage renal failure. Smoking is particularly "nephrotoxic" in older subjects, subjects with essential hypertension and patients with preexisting renal disease. Of interest, the magnitude of the adverse renal effect of smoking seems to be independent of the underlying renal disease. Death-censored renal graft survival is decreased in smokers, indicating that smoking also damages the renal transplant. Cessation of smoking has been show to reduce the rate of progression of renal failure both in patients with renal disease or a renal transplant. The mechanisms of smoking-induced renal damage are only partly understood and comprise acute hemodynamic (e.g., increase in blood pressure and presumably intraglomerular pressure) and chronic effects (e.g., endothelial cell dysfunction). Renal failure per se leads to an increased cardiovascular risk. The latter is further aggravated by smoking. Particularly survival of smokers with diabetes mellitus on hemodialysis is abysmal. In the present review article the current state of knowledge about the renal risks of smoking is reviewed. It is the aim of the article to point out that smoking not only increases the risk of renal cell carcinoma or uroepithelial cell carcinoma, but also the risk of a faster decline of renal function. The latter is a relatively new negative aspect which has not been widely recognized

Topics: Review
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2671650
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. The New England
    2. (2000). A multidisciplinary renal clinic for corticosteroid-induced bone disease. Pharmacotherapy
    3. (1996). A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene.
    4. (1990). A study of patients with diabetes mellitus (type 1) and end-stage renal failure: tobacco usage may increase risk of nephropathy and death.
    5. (2002). Adverse effect of smoking on renal function in the general population: Are men at higher risk?
    6. (2001). Adverse effects of smoking in the renal patient.
    7. (1994). Albuminuria in normals and essential hypertension.
    8. (1996). Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners.
    9. (1999). Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clinical Nephrology
    10. (1996). An observational study of cardiovascular characteristics of long-term end-stage renal disease survivors.
    11. (1999). Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers. Clinical Pharmacology and Therapeutics
    12. (2001). Are demographic characteristics of hypertensive patients different with renal artery stenosis?
    13. (2000). Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension
    14. (1998). Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysis.
    15. (1993). Association between smoking and micro-albuminuria in hypertensive patients with type 2 diabetes mellitus.
    16. (1991). Association of cigarette smoking with diabetic retinopathy. Diabetes Care
    17. (2001). Association of smoking with albuminuria in a cross-sectional probability sample of U.S. adults.
    18. (2000). Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney International
    19. Atherosclerotic complications after renal transplantation.
    20. (2000). Bielsa Marsol I, Ferrandiz Foraster C. Cholesterol embolism disease: study of 16 cases. Revista Clinica Espanola
    21. Blood pressure and endstage renal disease in men. The New England
    22. (2000). blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney International
    23. (1999). Blood pressure and the risk of complex arrhythmia in renal insufficiency, hemodialysis, and renal transplant patients.
    24. (1983). Cardiac arrhythmias in patients on maintenance hemodialysis. Nephron
    25. (1997). Cardiac disease in diabetic end-stage renal disease. Diabetologia
    26. (1996). Cardiovascular disease after renal transplantation.
    27. (1998). Cardiovascular disease: risk factors, secular trends, and therapeutic guidelines.
    28. (2001). Cardiovascular risk factors and the long-term outcome of lupus nephritis.
    29. (1998). Changes in youth cigarette use and intentions following implementation of a tobacco control program: findings from the Florida Youth Tobacco Survey,
    30. (2000). Cholesterol crystal embolism: A recognizable cause of renal disease.
    31. (1995). Chronic rejection in renal allografts: importance of cardiovascular risk factors. Clinical Transplantation
    32. (2002). Cigarette smoke condensate aggravates renal injury in the renal ablation model.
    33. (1976). Cigarette smoking and coronary artery disease. A macroscopic and microscopic study. Chest
    34. (1994). Cigarette smoking and diabetes: an update. Diabetic Medicine
    35. (1977). Cigarette smoking and diabetic retinopathy. Diabetes
    36. (1995). Cigarette smoking and ESRD incidence in men screened for the MRFIT.
    37. (2001). Cigarette smoking and glomerular ultrastructure in type 2 diabetes.
    38. (1983). Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. The Lancet
    39. (2000). Cigarette smoking and other inhaled toxins in anti-GBM disease. Contributions to Nephrology
    40. (2000). Cigarette smoking and pauci-immune extracapillary glomerulonephritis with ANCA-associated idiopathic systemic vasculitis. A retrospective study. Contributions to Nephrology
    41. (1978). Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care
    42. (2000). Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Annals of Internal Medicine
    43. (1996). Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology
    44. (2002). Cigarette smoking and vascular pathology in renal biopsies.
    45. (2000). Cigarette smoking in renal transplant recipients.
    46. (1991). Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes.
    47. (2000). Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension.
    48. (2002). Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition.
    49. (2000). Cigarette smoking, endothelial injury and cardiovascular disease.
    50. (1986). Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia
    51. (1994). Clinical aspects of cardiomyopathy in dialysis patients. Blood Purification
    52. (2000). Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clinical Nephrology
    53. (2001). Clinical characteristics of ischaemic renal disease. Nephrology Dialysis Transplantation
    54. (1995). Clinical factors associated with urinary albumin excretion in type II diabetes.
    55. (1992). Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking.
    56. (1997). Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Diabetologia
    57. (1998). Contrasting renal effects of nicotine in smokers and non-smokers. Nephrology Dialysis Transplantation
    58. (1994). Course and prognosis of anti-basement membrane antibody (antiBM-Ab)-mediated disease: report of 35 cases. Nephrology Dialysis Transplantation
    59. (2000). Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients.
    60. (2001). DD ACE genotype and smoking cluster with high-normal albuminuria: A cross sectional analysis in 1209 normo-albuminuric type 2 diabetics enrolled in the BErgamo NEphrologic DIabetes Complications Trial (BENEDICT).
    61. (1995). Death during the first 90 days of dialysis: a case control study.
    62. (1907). Der Einfluss des Rauchens auf den Kreislauf. Deutsches Archiv für Klinische Medizin
    63. (2001). Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort.
    64. (1988). Diabetic nephropathy. A clinical study of risk factors in type-I diabetes mellitus.
    65. (1993). Donor factors in cadaveric renal transplantation. Clinical Transplantation
    66. (1998). E, in collaboration with
    67. (2000). Early and long-term results of coronary artery bypass grafting in dialysis patients. Annals of Thoracic Surgery
    68. (1995). Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension
    69. (1993). Effect of cigarette smoking on cultured human endothelial cells. Cardiovascular Research
    70. (1998). Effect of end-stage renal disease on decreased heart rate variability.
    71. (1983). Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron
    72. (2000). Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney International
    73. (1999). Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension
    74. (1998). Effects of smoking on 24-h ambulatory blood pressure and autonomic function in normoalbuminuric insulin-dependent diabetes mellitus patients.
    75. (1996). Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy.
    76. (1998). Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease.
    77. (1991). Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study.
    78. (1993). Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice",
    79. (2001). Excess risk of renal allograft loss associated with cigarette smoking. Transplantation
    80. (1995). Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.
    81. (1994). glycohemoglobin, cholesterol, and smoking in subjects dying of coronary heart disease. Modern Pathology
    82. (1971). Heart rate and carbon monoxide level after smoking high-, low-, and non-nicotine cigarettes. A study in male patients with angina pectoris.
    83. (2001). Hemodialysis is diabetic patients.
    84. (2000). Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease. Diabetes Research and Clinical Practice
    85. (1993). How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects.
    86. (2001). How important is atheromatous renal artery stenosis as a cause of end-stage renal disease? Seminars in Dialysis
    87. (2000). hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney International
    88. (1995). Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients. Medicine (Baltimore)
    89. (2002). Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Human Pathology
    90. (1997). Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract--role of free radicals and attenuation by captopril. Atherosclerosis
    91. (1992). Implications for micro- and macrovascular disease. Diabetes Care
    92. (2000). Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders. Ophthalmic Epidemiology
    93. (1993). Incidence of gross proteinuria in older-onset diabetes. A population-based perspective. Diabetes
    94. Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients. The New England
    95. (2001). Increasing the diagnostic yield of renal angiography for the diagnosis of atheromatous renovascular disease.
    96. (1997). Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.
    97. (1997). Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients. Clinical Nephrology
    98. (2002). Influence of smoking and obesity on the development of proteinuria.
    99. (1996). Influence of smoking on the survival rate of diabetic patients requiring hemodialysis. Diabetes Care
    100. (2000). Is smoking a risk factor for progression of chronic renal failure? Kidney International
    101. (2002). Ischemic heart disease after renal transplantation.
    102. (1996). Knechtle SJ, D'Alessandro AM. Foot problems in the diabetic transplant recipient. Clinical Transplantation
    103. (1985). Longitudinal studies on the rate of decline in renal function with age.
    104. (1996). Longterm outcome of diabetic patients receiving peritoneal dialysis.
    105. (2000). Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population. Clinical Chemistry and Laboratory Medicine
    106. (1987). Low-output left ventricular failure in endstage renal disease.
    107. (1994). Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation
    108. (1997). Microalbuminuria and essential hypertension: renal and cardiovascular implications.
    109. (1999). Microalbuminuria in essential hypertension.
    110. (2002). Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study.
    111. (2001). Microalbuminuria in hypertensive, non-proteinuric renal transplant recipients: role of previous acute rejection episodes and sodium intake.
    112. (2001). Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity.
    113. (1987). Multi-centre study on outcome of treatment in patients on continuous ambulatory peritoneal dialysis and haemodialysis. Nephrology Dialysis Transplantation
    114. (1984). Myocardial and renal arteriolar thickening in cigarette smokers. Atherosclerosis
    115. (1999). Nephropathy in patients with type 2 diabetes mellitus.
    116. (1995). New variables reported to the UNOS registry and their impact on cadaveric renal transplant outcomes - a preliminary study. Clinical Transplantation
    117. (1997). Nicotine and sympathetic neurotransmission. Cardiovascular Drugs and Therapy
    118. (1994). Night blood pressure and cigarette smoking: disparate association in healthy subjects and diabetic patients. Blood Pressure
    119. (1985). One hundred cases of arteriovenous fistula for haemodialysis access: the effect of cigarette smoking on patency. Australian and New Zealand Journal of Surgery
    120. (1990). Outcome of renal replacement treatment in patients with diabetes mellitus.
    121. (1998). Outcome of renal transplantation in ninety-seven cyclosporine-era patients with systemic lupus erythematosus and matched controls. Arthritis and Rheumatism
    122. (1994). Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease.
    123. (1996). Parving HH. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
    124. (1999). Patient survival after renal transplantation: II. The impact of smoking. Clinical Transplantation
    125. (2002). Peripheral Vascular Disease Risk Factors among Patients Undergoing Hemodialysis.
    126. (2000). Peripheral vascular occlusive disease in renal transplant recipients: risk factors and impact on kidney allograft survival. Transplantation
    127. (1992). Persistent blood pressure increase induced by heavy smoking.
    128. (2000). Pharmacokinetics of nicotine in kidney failure. Clinical Pharmacology and Therapeutics
    129. (2001). Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: a preliminary analysis.
    130. (1983). Postrenal transplant erythrocytosis: a review of 53 patients.
    131. (2000). Predicting clinical outcome in the elderly renal transplant recipient.
    132. (1997). Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia
    133. (2001). Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study.
    134. (2000). Prevalence and determinants of microalbuminuria in highrisk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care
    135. (1996). Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care
    136. (1992). Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects.
    137. (1999). Prevalence of angiographic atherosclerotic renal artery disease and its relationship to the anatomical extent of peripheral vascular atherosclerosis. Nephrology Dialysis Transplantation
    138. Prevalence of symptomatic arterial disease and risk factors for its development in patients on continuous ambulatory peritoneal dialysis.
    139. (1992). Primary glomerulonephritis and hydrocarbon exposure: a case-control study and literature review.
    140. (2000). Progression of macrovascular disease after transplantation. Transplantation
    141. (1995). Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men.
    142. (1995). Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men.
    143. (2002). Psychosocial predictors of non-compliance in haemodialysis and peritoneal dialysis patients. Nephrology Dialysis Transplantation
    144. (1994). Relationship of smoking and albuminuria in children with insulin-dependent diabetes. Diabetic Medicine
    145. (2001). Renal artery stenosis: a common, treatable cause of renal failure? Annual Review of Medicine
    146. (1996). Renal findings in patients with short-term type 2 diabetes.
    147. (1996). Renal function in long-duration type I diabetes. Diabetes Care
    148. (1997). Renal function in the elderly--is the dogma of an inexorable decline of renal function correct? Nephrology Dialysis Transplantation
    149. (2001). Renal function: the Cinderella of cardiovascular risk profile.
    150. (1999). Renal hemodynamic changes during smoking: effects of adrenoreceptor blockade.
    151. (1998). Renal impairment in chronic cigarette smokers.
    152. (2001). Renal involvement in subjects with peripheral atherosclerosis.
    153. (1997). Renal involvement in type 1 (IDDM) diabetes in Spain.
    154. (2001). Renal vascular changes in renal disease independent of hypertension. Nephrology Dialysis Transplantation
    155. (1995). Renovascular disease in older patients beginning renal replacement therapy.
    156. (1999). Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus. Clinical Nephrology
    157. (1999). Risk factors for cancer in renal transplant recipients. Transplantation
    158. (1993). Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study.
    159. (1996). Risk factors for hospital utilization in chronic dialysis patients.
    160. (1999). Risk factors for IgA nephropathy: a case-control study in Japan.
    161. (1997). Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study.
    162. (2001). Risk factors for renal failure: the WHO Mulinational Study of Vascular Disease in Diabetes. Diabetologia
    163. (1999). Sharing crossreactive groups of MHC class I improves long-term graft survival. Kidney International
    164. (2001). Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis.
    165. Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrology Dialysis Transplantation 1994; 9: 1097-1102.Smoking – a renal risk factor 151
    166. (2001). Smoking and atheromatous stenosis of the renal arteries.
    167. (1978). Smoking and diabetic microangiopathy. The Lancet
    168. (1984). Smoking and diabetic nephropathy.
    169. (1993). Smoking and hypertension. Clinical and Experimental Hypertension
    170. (2002). Smoking and proteinuria impair vasodilatory response of intrarenal arteries to nitroglycerine in patients with type 2 diabetes mellitus. Nephrology Dialysis Transplantation
    171. (2002). Smoking and the kidney.
    172. (1999). Smoking cessation and tobacco control: an overview. Chest
    173. (2001). Smoking cessation in the hospitalized patient using the transtheoretical model of behavior change. Heart and Lung
    174. (2001). Smoking cessation strategies for the 21st century. Circulation
    175. (1984). Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Medica Scandinavica
    176. (1994). Smoking is associated with progression of diabetic nephropathy. Diabetes Care
    177. (2002). Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabets, Obesity and Lifestyle Study.
    178. (2000). Smoking is related to albuminuria and abnormal renal function in nondiabetic persons.
    179. (2000). Smoking--a renal risk factor. Nephron
    180. (1999). Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients.
    181. (1993). Survival and predictors of death in dialysed diabetic patients. Diabetologia
    182. (2001). Sympathetic overactivity and arterial hypertension in renal failure. Nephrology Dialysis Transplantation
    183. (1939). Tabak und Organismus. Handbuch der gesamten Tabakkunde.
    184. (1995). Ten-year incidence of gross proteinuria in people with diabetes. Diabetes
    185. (1996). The acute effect of smoking on systemic haemodynamics, kidney and endothelial functions in insulin-dependent diabetic patients with microalbuminuria.
    186. (2001). The appearance of retinopathy and progression to proliferative retinopathy: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia
    187. The epidemiology and prevalence of diabetic retinopathy in the Veneto region of north east Italy. Veneto Group for Diabetic Retinopathy. Diabetic Medicine 1991; 8 Spec No:
    188. (1996). The influence of chronic smoking on the diurnal rhythm of blood pressure in healthy individuals and in insulin dependent diabetic patients. Nephrology Dialysis Transplantation
    189. (1987). The natural history of insulin-dependent diabetes mellitus in Denmark: 1. Long-term survival with and without late diabetic complications. Diabetic Medicine
    190. (1999). The paradox of the low-renin state in diabetic nephropathy.
    191. (1994). The predictive value of microalbuminuria in IDDM. A five-year follow-up study. Diabetes Care
    192. (1993). The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town. Eye
    193. The primary prevention of myocardial infarction.
    194. (1995). The relationship between smoking and microvascular complications
    195. (1997). The renal risks of smoking.
    196. Thickening of walls of arterioles and small arteries in relation to age and smoking habits. The New England
    197. (1987). Tobacco and end stage diabetic nephropathy.
    198. (1998). Trends in smokingrelated diseases. Why smoking cessation is still the best medicine. Postgraduate Medicine
    199. (1997). Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.